Edition:
United States

Regenxbio Inc (RGNX.OQ)

RGNX.OQ on NASDAQ Stock Exchange Global Select Market

26.85USD
16 Feb 2018
Change (% chg)

$0.05 (+0.19%)
Prev Close
$26.80
Open
$26.70
Day's High
$27.10
Day's Low
$26.55
Volume
38,050
Avg. Vol
96,303
52-wk High
$36.35
52-wk Low
$16.30

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.34 -0.669
Jun '17 6.56 -0.472
Mar '17 0.46 -0.825
FY 2016 Dec '16 1.70 -0.741
Sep '16 0.12 -0.686
Jun '16 2.38 -0.548
Mar '16 0.39 -0.409
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.60 1.20 0.00 2.00
Quarter Ending Jun-18 2 0.60 1.20 0.00 2.00
Year Ending Dec-18 4 10.65 23.30 0.00 9.17
Earnings (per share)
Quarter Ending Mar-18 2 -0.79 -0.69 -0.88 -0.62
Quarter Ending Jun-18 2 -0.78 -0.64 -0.92 -0.57
Year Ending Dec-18 5 -2.77 -1.43 -3.51 -2.43
LT Growth Rate (%) 1 -7.10 -7.10 -7.10 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.11 34.43
P/E High - Last 5 Yrs. -- 280.23 46.75
P/E Low - Last 5 Yrs. -- 91.71 24.14
Beta -- 0.82 0.81
Price to Sales (TTM) 83.22 140.57 8.57
Price to Book (MRQ) 4.29 18.76 5.14
Price to Tangible Book (MRQ) 4.30 25.38 6.30
Price to Cash Flow (TTM) -- 118.58 25.75
% Owned Institutions 70.61 12.07 2.33

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.27
Payout Ratio(TTM) -- 9.21 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 968.80 43.07 9.45
Sales (TTM) vs TTM 1 Yr. Ago 37.02 45.64 7.30
Sales - 5 Yr. Growth Rate -- 32.43 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 2.42 0.41 20.15
EPS (TTM) vs TTM 1 Yr. Ago -47.14 -- --
EPS - 5 Yr. Growth Rate -- 44.88 11.48
Capital Spending - 5 Yr. Growth Rate -- 41.98 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.78 2.42
Current Ratio (MRQ) 12.85 6.17 3.38
LT Debt to Equity (MRQ) 0.00 16.64 11.85
Total Debt to Equity (MRQ) 0.00 18.80 15.12
Interest Coverage (TTM) -- -165.32 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 75.91 50.23 54.90
Gross Margin - 5 Yr. Avg. -- 55.34 52.64
EBITD Margin (TTM) -770.28 -- --
EBITD - 5 Yr. Avg -- -567.40 9.86
Operating Margin (TTM) -793.67 -697.09 1.25
Operating Margin - 5 Yr. Avg. -- -588.12 5.07
Pre-Tax Margin (TTM) -768.38 -664.73 2.12
Pre-Tax Margin - 5 Yr. Avg. -- -596.31 5.33
Net Profit Margin (TTM) -764.06 -659.23 -1.38
Net Profit Margin - 5 Yr. Avg. -- -600.20 1.62
Effective Tax Rate (TTM) -- 1.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 18.11 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 93,916 23,305,201 819,569,446
Net Income/Employee (TTM) -717,570 -626,600 95,804,981
Receivable Turnover (TTM) 12.86 15.04 5.40
Inventory Turnover (TTM) -- 2.52 3.48
Asset Turnover (TTM) 0.05 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -37.89 -1.27 10.68
Return on Assets - 5 Yr. Avg. -- -0.48 12.00
Return on Investment (TTM) -40.68 -1.15 13.54
Return on Investment - 5 Yr. Avg. -- 2.13 15.72
Return on Equity (TTM) -40.96 -20.84 14.80
Return on Equity - 5 Yr. Avg. -- -2.48 16.91
  1 Year 3 Year 5 Year
Sales % -39.52 -8.99 --
EPS (TTM) % -146.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Regenxbio Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -0.92 1.91 55 71
13 Week -2.54 -8.01 41 93
26 Week 34.59 19.48 71 86
52 Week 52.99 31.43 75 87
YTD -19.25 -20.98 14 90
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 70.62%
# of Holders: 166
Total Shares Held: 21,993,826
3 Mo. Net Change: 285,724
# New Positions: 36
# Closed Positions: 14
# Increased Positions: 83
# Reduced Positions: 61
# Net Buyers: 22
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.